Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01670097 · ClinicalTrials.gov registry record · Phase 2
Dexamethasone Dyspnea Study
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT01670097: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT01670097 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01670097, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if dexamethasone can help reduce shortness of breath in cancer patients. Researchers also want to learn if it can help to improve lung function and quality of life. In this study, dexamethasone will be compared to a placebo. Dexamethasone is commonly used for treatment of nausea, tiredness, and pain. It may help patients with shortness of breath. A placebo is not a drug. It looks like the study drug but is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.
Interventions
- DRUG Placebo
- DRUG Dexamethasone
- BEHAVIORAL Questionnaires
- OTHER Phone Calls
- DEVICE Spirometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2013-01 |
| Est. Completion | 2021-01-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01670097
The ClinicalTrials.gov registry entry for NCT01670097 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT01670097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01670097 about?
NCT01670097 is a clinical study titled "Dexamethasone Dyspnea Study". The goal of this clinical research study is to learn if dexamethasone can help reduce shortness of breath in cancer patients. Researchers also want to learn if it can help to improve lung function and quality of life. In this study, dexamethasone will be compared to a placebo. Dexamethasone is comm...
What is the current status of trial NCT01670097?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2013-01. Estimated completion is 2021-01-26.
What interventions are being tested in trial NCT01670097?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG), Questionnaires (BEHAVIORAL), Phone Calls (OTHER), Spirometer (DEVICE).
Who is sponsoring clinical trial NCT01670097?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.